Mayo Clinic completes first genome-wide analysis of peripheral T-cell lymphomas
by on Friday, August 3rd, 2012 | No Comments
Cancer News
- Bladder Cancer (65)
- Brain Tumor Cancer (38)
- Breast Cancer (8038)
- Cancer Bulletins (543)
- Cancer Clinical Trials (5106)
- Cancer Treatment (1201)
- Colon Rectal Cancer (5951)
- General Cancer (16801)
- Leukemia Lymphoma Cancer (10572)
- Lung Mesothelioma Asbestos (4824)
- Ovarian Cervical Uterine Cancer (1137)
- Pancreatic Cancer (56)
- Prostate Cancer (6895)
- Skin Cancer (6030)
- Uncategorized (53)
-
Cancer News Topics
- Cancer Cause Directs Treatment 0314.2013-13.23
- Compound in Mediterranean diet makes cancer cells ‘mortal’
- Timing of cancer radiation therapy may minimize hair loss
- Hairdressers to boost cancer treatment fund
- Commonly used catheters double risk of blood clots in ICU and cancer patients
- Molecular marker from pancreatic ‘juices’ helps identify pancreatic cancer
- Nonmelanoma Skin Cancers Can Be Dangerous, Disfiguring and Deadly
- Samantha gets the chop for cancer charity
- Big Data Unveils Exciting Head and Neck Cancer Targets
- Lung Cancer Living Room 4-16-13
- Isabelle Daza talks about Cervical Cancer
- PROSTATE CANCER VIDEO "Surgery"
- Doctors narrow guidelines for prostate cancer screening
- Bringing a New Stem Cell Treatment to Cancer Patients: Dr. Karen Aboody, M.D. at TEDxAJU
- Bionimbus protected data cloud to enable researchers to analyze cancer data
- Genetic diversity within tumors predicts outcome in head and neck cancer
- Mechanism linking key inflammatory marker to cancer identified
- Pioneers of revolutionary cancer treatment mark 1,000th patient milestone at Basingstoke hospital
- Lecture to focus on cancer research success
- County Museum Profiles History of Regional Asbestos Use
- YMCA Program Targets Cancer Survivors, Families
- Jay Leno Hosts Magical Evening for New Partnership for Cancer Care
- Depressive Symptoms Are Linked To Early Death In Cancer Survivors
- Mesothelioma Patients Should Benefit from Organization’s Goal of Doubling Five-Year Survival Rates for Lung Cancer
- Mesothelioma Patients Should Benefit from Organization’s Goal of Doubling Five-Year Survival Rates for Lung Cancer